Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-21522 · Session 1

Why the Beatson Oncology Centre does not make Herceptin available for NHS patients given that one of the three HER2 testing reference labor…

Answered Asked by Dorothy-Grace Elder SNP Lodged 7 Jan 2002

The question

To ask the Scottish Executive why the Beatson Oncology Centre does not make Herceptin available for NHS patients given that one of the three HER2 testing reference laboratories in the UK funded by a drug company is based there.

The answer

Answered by Malcolm Chisholm on 21 Jan 2002 · 14 days after it was lodged, on time

The National Institute for Clinical Excellence is expected to provide guidance on the use of Trastuzamab in the near future.Pending this guidance and Health Technology Board for Scotland Comment, Herceptin is currently supported by NHS Greater Glasgow and many other NHS Boards across Scotland within locally agreed clinical protocols and based on individual clinical assessments.

In the Official Report

No contribution in the Official Report cites S1W-21522 by reference.